Industry News


Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info



NATHEALTH and APACMED join hands to advance medical technology for UHC in India

In India, the government schemes such as Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) and Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana have helped India take bold steps towards UHC.

New Delhi, September 9, 2020: India is committed to meeting UNSDGs and SDG 3 is a critical goal, that impact all others. Further, advancing medical technology is pivotal to achieving Universal Health Coverage (UHC) in India. In keeping with the above, the industry body, NATHEALTH - Healthcare Federation of India, renowned as the credible voice of the health sector of India and the Asia Pacific Medical Technology Association (APACMed), the regional association of medical technology in the Asia Pacific today signed a Memorandum of Understanding (MoU) to harness the role of the medical technology industry in India, in relation to AB-PMJAY and to ensure that it optimally engages with relevant policymakers, helping shape polices leading to achieving UHC in India.

The goal of this strategic partnership is to enable a seamless pathway that streamlines all innovations ensuring that it scales and increases the concerted efforts by both organizations. Both NATHEALTH and APACMed would work through a joint working group in formulating a work plan in relation to Universal Healthcare in India, that would synergize and complement the efforts of the government to maximize patient health outcomes through quality care relative to expenditures.

Speaking about the partnership, Ms. Preetha Reddy, President – NATHEALTH & Vice Chairperson, Apollo Hospitals said, “The COVID-19 pandemic has been highlighting the fault lines even in the most advanced nations and underlined the acute need for a robust mechanism for UHC.

In India, the government schemes such as Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) and Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana have helped India take bold steps towards UHC. Now going forward, it is vital that there are strong collaborative efforts by the government and private health sector organizations, which will be the key to digitally transform the Indian healthcare system. The MoU and partnership between NATHEALTH and APACMeD will work to increase access to innovative medical technologies, that which will lead to high quality and affordable healthcare delivery and complement the efforts of the Government’s UHC agenda.

Kraton’s BIAXAM kills up to 99.99% of microbes including SARS-CoV-2

Kraton Corporation, a leading global producer of specialty polymers and high-value bio-based products, is seeking regulatory approval for BIAXAM, a novel sulfonated polymer technology with long-lasting self-disinfecting properties that has been demonstrated in studies to quickly inactivate up to 99.99% of SARS-CoV-2 (virus that causes COVID-19) and other microbes. Kraton developed the BIAXAM technology as part of its sulfonated polymer product line and plans to expand product testing and seek regulatory approval for use as a durable, long-lasting disinfectant from the United States Environmental Protection Agency (EPA).

The efficacy of Kraton's BIAXAM technology has been thoroughly studied by renowned organizations. The testing performed at the UTMB and Boston University BSL-4 laboratories has demonstrated BIAXAM to be effective against SARS-CoV-2 and other microbes.

Depending on the regulatory approval process or certification requirements by country, Kraton believes that BIAXAM could be used as a coating on PPE and a variety of high-contact surfaces. Additionally, it could be used as a replaceable peel-and-stick film for a broad range of applications including medical, textiles, building and construction, and packaging.

SVP and CTO Dr Vijay Mhetar said: "BIAXAM offers rapid and long-lasting performance, unlike current disinfectant offerings that are only effective immediately or require periodic treatment or re-application. Currently there are no EPA-approved long-lasting disinfectants, so this technology is truly extraordinary. We believe the EPA would approve BIAXAM for the US market and allow us to market the solution due to the novel anti-microbial properties it has demonstrated."

The BIAXAM technology is patent-pending and will be commercially available shortly. For the US market, until EPA approval is obtained, BIAXAM cannot be sold, marketed or distributed as components of products that kill or repel or claim to kill or repel microbes such as virus, bacteria or mold.

President and CEO Kevin M. Fogarty added: "We've been developing this technology for some time for other applications, but the recent pandemic has led to an urgent and high demand for anti-microbial materials. We are excited about the possibility of bringing this innovation to market. We are currently conducting discussions with a number of possible development partners to explore potential applications."

Other News

Hindustan Syringes Sends Over 56 Million Pieces to Covax Facility
Japan Commits Rs 3500Cr To Strengthen Indian Health Sector
Medical Device Industry Demands Separate Marketing Practices Code Different From Pharma Industry
COVID-19 Treatment: CDSCO Shows Green Flag To Baxter India Oxiris Filter
SCTIMST inks MoU with Tynor Orthotic to boost orthotic devices
IPC Rolls Out PPE Adverse Event Reporting Form As Part Of MvPI For Patient And Health Worker Safety
Medical device importers ask govt to incentivize innovations for economies of scale for affordability
Goa hopes to qualify for medical device park, appoints consultant
Kerala to have one of the first medical device parks
German glassmaker SCHOTT AG appoints Pawan Kumar Shukla as MD
MEDICA and COMPAMED go virtual
Anti-bacterial film developed for touchscreen medical devices
Messe Frankfurt India plans to launch Medical Device Innovation Summit as large format event in 2020
Best time to invest in pharma, medical device sector: DV Sadananda Gowda
CHP to offer expert consultative advice for setting up medical device and pharma parks in UP
Indian Medical Device Industry, growing faster during COVID-19 pandemic
VIEW: Untold story of Indian medtech and how to make it ‘Atmanirbhar’
Govt lifts ban on export of PPE suits, face masks, hand sanitisers
From Being A Net Importer, India Now Manufactures Over 5 Lakh PPE Kits Per Day: Union Minister Sadananda Gowda
Abbott launches heart rhythm management devices in India
Ceresana Examines the World Market for Thermoplastic elastomers





Back | Back To Top | Previous